Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 180

1.

The role of GDF11 in aging and skeletal muscle, cardiac and bone homeostasis.

Egerman MA, Glass DJ.

Crit Rev Biochem Mol Biol. 2019 Apr;54(2):174-183. doi: 10.1080/10409238.2019.1610722.

PMID:
31144559
2.

Growth differentiation factor 11 inhibits adipogenic differentiation by activating TGF-beta/Smad signalling pathway.

Luo H, Guo Y, Liu Y, Wang Y, Zheng R, Ban Y, Peng L, Yuan Q, Liu W.

Cell Prolif. 2019 Apr 30:e12631. doi: 10.1111/cpr.12631. [Epub ahead of print]

PMID:
31038259
3.

Identification of the minimum region of flatfish myostatin propeptide (Pep45-65) for myostatin inhibition and its potential to enhance muscle growth and performance in animals.

Kim JH, Kim JH, Sutikno LA, Lee SB, Jin DH, Hong YK, Kim YS, Jin HJ.

PLoS One. 2019 Apr 18;14(4):e0215298. doi: 10.1371/journal.pone.0215298. eCollection 2019.

4.

[Effects of Low-Dose Decitabine on Soluble CD44, GDF11 Levels and Hematopoietic Function in Elderly Patients with MDS].

Guo SQ, Shi R, Chen YY, Liu S, Li YH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Apr;27(2):509-514. doi: 10.19746/j.cnki.issn.1009-2137.2019.02.032. Chinese.

PMID:
30998162
5.

GDF11 upregulation independently predicts shorter overall-survival of uveal melanoma.

Liu X, Zhang Q, Fan C, Tian J, Liu X, Li G.

PLoS One. 2019 Mar 18;14(3):e0214073. doi: 10.1371/journal.pone.0214073. eCollection 2019.

6.

GDF11 is increased in patients with aplastic anemia.

Dong X, Han Y, Abeysekera IR, Shao Z, Wang H.

Hematology. 2019 Dec;24(1):331-336. doi: 10.1080/16078454.2019.1574386.

PMID:
30727851
7.

The Growth Differentiation Factor 11 is Involved in Skin Fibroblast Ageing and is Induced by a Preparation of Peptides and Sugars Derived from Plant Cell Cultures.

Tito A, Barbulova A, Zappelli C, Leone M, Ruvo M, Mercurio FA, Chambery A, Russo R, Colucci MG, Apone F.

Mol Biotechnol. 2019 Mar;61(3):209-220. doi: 10.1007/s12033-019-00154-w.

PMID:
30661170
8.

Recombinant growth differentiation factor 11 impairs fracture healing through inhibiting chondrocyte differentiation.

Zheng R, Xie L, Liu W, Guo Y, Wang Y, Wu Y, Liu Y, Luo H, Kang N, Yuan Q.

Ann N Y Acad Sci. 2019 Mar;1440(1):54-66. doi: 10.1111/nyas.13994. Epub 2018 Dec 21.

PMID:
30575056
9.

Relationship between serum level of growth differentiation factors 8, 11 and bone mineral density in girls with anorexia nervosa.

Wu Y, Qu J, Li H, Yuan H, Guo Q, Ouyang Z, Lu Q.

Clin Endocrinol (Oxf). 2019 Jan;90(1):88-93. doi: 10.1111/cen.13871. Epub 2018 Oct 25.

PMID:
30281844
10.

The GDF11-FTO-PPARγ axis controls the shift of osteoporotic MSC fate to adipocyte and inhibits bone formation during osteoporosis.

Shen GS, Zhou HB, Zhang H, Chen B, Liu ZP, Yuan Y, Zhou XZ, Xu YJ.

Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3644-3654. doi: 10.1016/j.bbadis.2018.09.015. Epub 2018 Sep 14.

PMID:
30279140
11.

GDF11 Antagonizes Psoriasis-like Skin Inflammation via Suppression of NF-κB Signaling Pathway.

Wang W, Qu R, Wang X, Zhang M, Zhang Y, Chen C, Chen X, Qiu C, Li J, Pan X, Li W, Zhao Y.

Inflammation. 2019 Feb;42(1):319-330. doi: 10.1007/s10753-018-0895-3.

PMID:
30259241
12.

Effect of GDF11 on proliferation and apoptosis of esophageal cancer cells.

Gu B, Wang Q, Dai W, Ma G, Song Y, Wu Q.

Cell Mol Biol (Noisy-le-grand). 2018 Aug 30;64(11):80-84.

PMID:
30213293
13.

Relationship of muscle function to circulating myostatin, follistatin and GDF11 in older women and men.

Fife E, Kostka J, Kroc Ł, Guligowska A, Pigłowska M, Sołtysik B, Kaufman-Szymczyk A, Fabianowska-Majewska K, Kostka T.

BMC Geriatr. 2018 Aug 30;18(1):200. doi: 10.1186/s12877-018-0888-y.

14.

Growth differentiation factor 11 worsens hepatocellular injury and liver regeneration after liver ischemia reperfusion injury.

Liu A, Dong W, Peng J, Dirsch O, Dahmen U, Fang H, Zhang C, Sun J.

FASEB J. 2018 Sep;32(9):5186-5198. doi: 10.1096/fj.201800195R. Epub 2018 Apr 17.

PMID:
29913561
15.

Physical inactivity is associated with decreased growth differentiation factor 11 in chronic obstructive pulmonary disease.

Tanaka R, Sugiura H, Yamada M, Ichikawa T, Koarai A, Fujino N, Yanagisawa S, Onodera K, Numakura T, Sato K, Kyogoku Y, Sano H, Yamanaka S, Okazaki T, Tamada T, Miura M, Takahashi T, Ichinose M.

Int J Chron Obstruct Pulmon Dis. 2018 Apr 24;13:1333-1342. doi: 10.2147/COPD.S157035. eCollection 2018.

16.

GDF11 induces kidney fibrosis, renal cell epithelial-to-mesenchymal transition, and kidney dysfunction and failure.

Pons M, Koniaris LG, Moe SM, Gutierrez JC, Esquela-Kerscher A, Zimmers TA.

Surgery. 2018 Aug;164(2):262-273. doi: 10.1016/j.surg.2018.03.008. Epub 2018 May 3.

17.

Reduced expression of growth differentiation factor 11 promoted the progression of chronic obstructive pulmonary disease by activating the AKT signaling pathway.

Tang F, Ling C, Liu J.

Biomed Pharmacother. 2018 Jul;103:691-698. doi: 10.1016/j.biopha.2018.04.091. Epub 2018 Apr 24.

PMID:
29680737
18.

GDF11/BMP11 as a novel tumor marker for liver cancer.

Zhang YH, Pan LH, Pang Y, Yang JX, Lv MJ, Liu F, Qu XF, Chen XX, Gong HJ, Liu D, Wei Y.

Exp Ther Med. 2018 Apr;15(4):3495-3500. doi: 10.3892/etm.2018.5861. Epub 2018 Feb 12.

19.

Neonatal Systemic AAV-Mediated Gene Delivery of GDF11 Inhibits Skeletal Muscle Growth.

Jin Q, Qiao C, Li J, Li J, Xiao X.

Mol Ther. 2018 Apr 4;26(4):1109-1117. doi: 10.1016/j.ymthe.2018.01.016. Epub 2018 Feb 2.

20.

Growth Differentiation Factor 11 Promotes Abnormal Proliferation and Angiogenesis of Pulmonary Artery Endothelial Cells.

Yu X, Chen X, Zheng XD, Zhang J, Zhao X, Liu Y, Zhang H, Zhang L, Yu H, Zhang M, Ma C, Hao X, Zhu D.

Hypertension. 2018 Apr;71(4):729-741. doi: 10.1161/HYPERTENSIONAHA.117.10350. Epub 2018 Feb 20.

PMID:
29463625

Supplemental Content

Loading ...
Support Center